Leadership Overview
Takeda has 10 executives leading key functions including transformation, neuroscience, marketing, strategic programs, human resources, research and development, regulatory operations, regional operations, finance, and supply chain.
Focused on advancing global health through innovative pharmaceutical research, Takeda delivers life-changing therapies across gastroenterology, oncology, and neuroscience while maintaining a commitment to patient-centric healthcare solutions.
Focused on advancing global health through innovative pharmaceutical research, Takeda delivers life-changing therapies across gastroenterology, oncology, and neuroscience while maintaining a commitment to patient-centric healthcare solutions.
Leadership Roles at Takeda
Nory Shiokawa - Senior VP & Chief Financial Officer, Growth & Emerging Markets Business Unit
Nory Shiokawa, the Senior VP & Chief Financial Officer, Growth & Emerging Markets Business Unit at Takeda, directs the financial strategy for the company's most dynamic regional markets. Shiokawa manages financial planning, budgeting, and performance analysis to ensure the profitability of the Growth and Emerging Markets business unit. By overseeing capital allocation, Shiokawa supports the expansion of the pharmaceutical portfolio in regions with high growth potential. This leadership role involves collaborating with regional heads to align financial targets with operational realities. Nory Shiokawa drives the implementation of financial controls that mitigate risk while enabling investment in new market opportunities. Through rigorous fiscal oversight, Shiokawa ensures that the business unit contributes significantly to the company's overall financial health. This position requires a focus on long-term value creation and the ability to navigate the economic complexities of diverse international markets while maintaining strict adherence to corporate financial standards.
Lindsay Gotts - Chief of Staff Transformation Lead
Lindsay Gotts, the Chief of Staff Transformation Lead at Takeda, directs organizational change initiatives to optimize operational efficiency. By aligning internal processes with the broader pharmaceutical research mission, Gotts ensures that cross-functional teams execute complex projects with precision. This leadership role involves streamlining communication channels between departments to accelerate the development of new medicines. Through rigorous analysis of internal workflows, Gotts identifies bottlenecks and implements scalable solutions that support the company's long-term growth objectives. As the Chief of Staff Transformation Lead, Gotts maintains a focus on enhancing productivity across global business units. By fostering a culture of continuous improvement, Lindsay Gotts drives the structural evolution necessary to maintain a competitive edge in the global healthcare market. This strategic oversight remains vital for the successful integration of new technologies into existing manufacturing and research frameworks.
Christopher Tremblay - Head Neuroscience Therapeutic Area & of Global Program Management Chief of Staff
Christopher Tremblay, the Head Neuroscience Therapeutic Area & of Global Program Management Chief of Staff at Takeda, oversees the advancement of innovative treatments for neurological disorders. Tremblay manages the strategic direction of the neuroscience portfolio, ensuring that research efforts align with unmet patient needs. By coordinating global program management, Tremblay synchronizes clinical development timelines with regulatory milestones. This leadership role requires constant collaboration with research scientists and commercial teams to bring therapies from the laboratory to the global market. Christopher Tremblay drives the prioritization of high-impact projects that address rare metabolic and neurodegenerative conditions. Through the effective allocation of resources, Tremblay maximizes the potential of the neuroscience pipeline. This position demands a deep understanding of both scientific innovation and operational execution, ensuring that the company remains at the forefront of neurological healthcare advancements while delivering consistent value to patients worldwide.
Allen Funk - Global Category Manager & Associate Director & Chief Marketing Officer, Pharm Sci Large Molecule
Allen Funk, the Global Category Manager & Associate Director & Chief Marketing Officer, Pharm Sci Large Molecule at Takeda, architects the commercial strategy for large molecule pharmaceutical products. Funk manages global category portfolios, ensuring that marketing initiatives effectively communicate the value of complex biological therapies to healthcare providers. By analyzing market trends and competitive landscapes, Funk identifies growth opportunities within the oncology and rare disease sectors. This leadership role involves close coordination with scientific teams to translate technical product benefits into clear market advantages. Allen Funk drives the execution of global marketing campaigns that expand the reach of large molecule treatments across diverse international markets. Through strategic brand positioning, Funk enhances the visibility of the company's specialized healthcare products. This role requires balancing scientific rigor with commercial agility to ensure that advanced therapies reach the patients who need them most effectively.
Amy Palmieri - Strategic Programs Lead & , Usbu Foundational Therapeutics Platform Chief of Staff
Amy Palmieri, the Strategic Programs Lead & , Usbu Foundational Therapeutics Platform Chief of Staff at Takeda, manages the execution of critical initiatives within the foundational therapeutics platform. Palmieri coordinates cross-functional efforts to ensure that core pharmaceutical products maintain high standards of quality and accessibility. By overseeing strategic program development, Palmieri aligns operational activities with the company's mission to provide essential healthcare solutions. This leadership role involves managing complex project lifecycles and ensuring that resources are deployed efficiently to support therapeutic platform goals. Amy Palmieri drives the implementation of process improvements that enhance the reliability of the supply chain for foundational medicines. Through rigorous project management, Palmieri supports the stability of the company's product offerings in the North American market. This position requires a focus on operational excellence and the ability to navigate the intersection of clinical requirements and business strategy.
Yuko Barnaby - Executive Assistant To Nicola Greenway, Chief Human Resources Officer
Yuko Barnaby, the Executive Assistant To Nicola Greenway, Chief Human Resources Officer at Takeda, facilitates the strategic operations of the human resources department. Barnaby manages the administrative infrastructure that supports global talent management and organizational development initiatives. By coordinating executive communications and scheduling, Barnaby ensures that the Chief Human Resources Officer remains focused on high-level workforce strategy and cultural transformation. This leadership role involves managing sensitive information and supporting the execution of corporate policies that impact employees across all global regions. Yuko Barnaby drives the efficiency of the HR leadership team by streamlining workflows and managing key stakeholder interactions. Through meticulous attention to detail, Barnaby supports the implementation of programs designed to attract and retain top talent in the pharmaceutical industry. This position serves as a critical link in the organizational hierarchy, ensuring that human capital strategies align with the company's broader business objectives.
Colleen Beauregard - Vice President and Chief of Staff, Global Research and Development
Colleen Beauregard, the Vice President and Chief of Staff, Global Research and Development at Takeda, directs the operational strategy for the company's extensive R&D division. Beauregard manages the integration of research activities across global sites, ensuring that scientific discovery aligns with corporate development goals. By overseeing the R&D portfolio, Beauregard facilitates collaboration between clinical researchers and executive leadership to accelerate the pipeline of new medicines. This leadership role involves managing the allocation of research budgets and ensuring that development milestones are met with precision. Colleen Beauregard drives the implementation of innovative research methodologies that enhance the efficiency of drug discovery. Through strategic oversight, Beauregard ensures that the company maintains a robust pipeline of therapies for rare diseases and oncology. This position requires a deep understanding of the pharmaceutical development lifecycle and the ability to manage complex, multi-disciplinary teams on a global scale.
Swarup Shetty - Director, Business Excellence & Global Regulatory Operations Chief of Staff
Swarup Shetty, the Director, Business Excellence & Global Regulatory Operations Chief of Staff at Takeda, oversees the optimization of regulatory processes and business performance. Shetty manages the integration of regulatory compliance with operational excellence initiatives to ensure that all pharmaceutical products meet global safety standards. By coordinating with regulatory bodies, Shetty facilitates the timely approval and launch of new therapies. This leadership role involves analyzing operational data to identify areas for process improvement within the regulatory framework. Swarup Shetty drives the adoption of digital tools that streamline documentation and reporting, enhancing the overall efficiency of the regulatory department. Through strategic planning, Shetty ensures that the company remains compliant while pursuing aggressive growth targets in international markets. This position requires a focus on both technical regulatory requirements and the broader business impact of maintaining high-quality standards across the global pharmaceutical portfolio.
John Tiong - Director, Regional Med Operations (Chief of Staff) and Plasma Derived Therapy Lead, GEM
John Tiong, the Director, Regional Med Operations (Chief of Staff) and Plasma Derived Therapy Lead, GEM at Takeda, manages medical operations and plasma-derived therapy initiatives within the Growth and Emerging Markets business unit. Tiong oversees the regional deployment of specialized therapies, ensuring that healthcare providers have access to essential plasma-based treatments. By coordinating medical operations, Tiong aligns regional clinical activities with the company's global therapeutic strategy. This leadership role involves managing complex supply chains and ensuring that medical education programs effectively support the adoption of new therapies. John Tiong drives the expansion of the plasma-derived therapy portfolio in emerging markets, focusing on increasing patient access to life-saving treatments. Through strategic regional management, Tiong ensures that the company's medical operations remain responsive to local healthcare needs while maintaining global quality standards. This position requires a balance of operational expertise and a deep commitment to improving patient outcomes.
Jessica Vieira - Global Supply & Quality Chief of Staff
Jessica Vieira, the Global Supply & Quality Chief of Staff at Takeda, manages the operational integration of global supply chain and quality assurance functions. Vieira oversees the coordination of manufacturing and distribution processes to ensure that all pharmaceutical products meet the highest quality standards before reaching patients. By aligning supply chain logistics with quality control protocols, Vieira minimizes disruptions and ensures the consistent availability of essential medicines. This leadership role involves managing cross-functional teams to resolve complex supply chain challenges and maintain compliance with international manufacturing regulations. Jessica Vieira drives the implementation of quality management systems that enhance the reliability of the global supply network. Through strategic oversight, Vieira supports the company's commitment to patient safety and operational excellence. This position requires a focus on both the technical aspects of quality assurance and the logistical demands of maintaining a global pharmaceutical supply chain.
Explore Leadership Teams in Manufacturing
GSK plc is a British multinational pharmaceutical and biotechnology company headquartered in London, United Kingdom. Established in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, GSK is the tenth-largest pharmaceutical company globally. The company discovers, develops, manufactures, and delivers medicines and vaccines with a research and development focus on four primary therapeutic areas: respiratory, immunology and inflammation, oncology, HIV, and infectious diseases. GSK's product portfolio includes specialty medicines, vaccines, and general medicines targeting conditions such as HIV, respiratory diseases, cancer, immuno-inflammation, anti-viral, central nervous system disorders, metabolic conditions, cardiovascular disease, urogenital conditions, anti-bacterial treatments, dermatology, and rare diseases. The company also offers over-the-counter products for pain relief, oral health, nutrition, skin health, and gastrointestinal diseases. GSK has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. In July 2024, the company moved its global headquarters to New Oxford Street in central London, positioning itself within the city's Knowledge Quarter near world-class science and academic institutions including the Francis Crick Institute and King's College London. The new headquarters houses approximately 3,000 employees including the global leadership team and teams supporting research and development, supply chain, commercial operations, and corporate functions. GSK sells its products through wholesalers, pharmacies, hospitals, physicians, and other healthcare groups globally, aiming to positively impact the health of 2.5 billion people by the end of the decade.
Company Leadership LT
PL
RH
Zydus is a global pharmaceutical company headquartered in Ahmedabad, India. Founded in 1952, the company operates manufacturing sites and research facilities across multiple states in India as well as in the United States and Brazil. Zydus specializes in developing, manufacturing, and distributing pharmaceutical products with a significant global footprint. The company maintains a strong presence in regulated markets including the United States, Europe, Latin America, and South Africa, while also serving numerous emerging markets worldwide. Zydus offers a comprehensive portfolio of pharmaceutical products and services, supported by extensive research and development capabilities.
Company Leadership HS
DN
NP
RemeGen is a biopharmaceutical company focused on developing innovative drugs for autoimmune diseases and cancers. Their flagship products include Telitacicept, a dual-target fusion protein for autoimmune conditions, and Disitamab Vedotin, an antibody-drug conjugate for cancer treatment. The company has a robust product pipeline with numerous drugs in various stages of research and development. RemeGen aims to serve patients globally, leveraging its advanced technology and strong scientific support.
Company Leadership JL
JF
KH
MS
Abdi Ibrahim provides pharmaceutical services to the healthcare sector that are beneficial in maintaining people's health. Abdi Ibrahim was founded in 1912 and is based in Istanbul, Turkey.
Company Leadership AO
MÇ
Frequently Asked Questions Regarding Takeda Top Executives and Leadership Team
